Labopharm Inc. (Public, NASDAQ:DDSS)
(Closed at $2.63 with strong volume of 4.27M, alerted at $2.35 on Jan15 LINK)
FDA action on once-daily formulation of Trazodone (DDS-04A) as treatment of major depressive disorder.
FDA approval decision date: Feb. 11, 2010
Bederra Corp New (Public, PINK:BEDA)
(Closed at 0.0024 with a huge volume of 407M, , alerted at $0.0011 today LINK)
Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas-based diversified medical services provider, has announced the Board of Directors will convene a special meeting to discuss a proposal to buy back a portion of the Company's issued and outstanding common stock. more
Tuesday, January 26, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment